Compare Box Inc (BOX) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Box Inc vs Sana Biotechnology Inc — how do they compare? Box Inc trades at $32.46 (market cap $4.55B), while Sana Biotechnology Inc trades at $3.8 (market cap $1.13B). The key difference: Box Inc is far larger — about 4× Sana Biotechnology Inc's market cap, and Box Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| BOX | SANA | |
|---|---|---|
Market Cap | $4.55B | $1.13B |
Sector | Technology | Health |
52-Week High | $33.60 | $5.92 |
52-Week Low | $21.37 | $2.68 |
Enterprise Value | $5.10B | $1.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BOX trades at $32.53, down 3.18% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $37.00. Revenue grew to $1.09 billion in 2025 with a net income margin of 22.43%, though the P/E ratio of 51.3 indicates a premium valuation. Recent news highlights Box's partnership with Quintas Energy for an AI-ready content platform, reinforcing its enterprise focus.
The outlook is positive with strong analyst support (60.72% buy ratings) and projected revenue growth to $1.2 billion in 2026. Risks include high valuation multiples and competitive pressures in cloud content management. Upside potential exists if earnings beat expectations, but investors should monitor debt levels and margin sustainability.
SANA Biotechnology trades at $3.77, up 4.43% today, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $244.17 million for 2025, with negative cash flow from operations, but analyst consensus is strongly positive with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 average price target from brokerages as of July 30, 2026.
The outlook hinges on clinical progress driving future profitability, but high cash burn and negative ROE pose significant risks. Upside potential exists if pipeline milestones are met, supported by institutional optimism, though investors face volatility from earnings misses and funding needs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Box Inc
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature that enhance workflow management and collaboration.
Read more on BOX →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
